Admin 08 Jun 2026 19:58

 

Understanding Wholesale Dealer's Licence (WDA(H))

Your Comprehensive Guide to WDA(H)

A Wholesale Dealer's Licence (WDA(H)) is a mandatory requirement for businesses involved in the storage or distribution of medicinal products for human use in the UK. Issued by the Medicines and Healthcare products Regulatory Agency (MHRA), this licence ensures that wholesale distribution activities comply with Good Distribution Practice (GDP).

What is a WDA(H)?

The WDA(H) is a legal requirement for any entity storing medicinal products before supplying them to others, with limited exceptions. It exists to guarantee that medicines remain safe, effective, and of high quality throughout the distribution chain. This licence covers wholesale distribution activities including procurement, holding, storage, and distribution of medicinal products.

Key Point: Even healthcare professionals who stock medicines for their own patients but also supply to other healthcare providers may need a WDA(H).

Who Needs a WDA(H)?

You may need a WDA(H) if your business:

  • Imports medicinal products from outside the UK
  • Distributes medicines to pharmacies, hospitals, or other healthcare providers
  • Manufactures medicines and also distributes them to third parties
  • Stores medicines prior to distribution
  • Sells medicines online to UK customers

The following entities are generally exempt:

  • Pharmacies supplying medicines directly to patients for whom they have been prescribed
  • Hospitals supplying medicines for their own patients
  • Doctors or dentists supplying medicines for their own patients
  • Veterinary practices supplying medicines for animals under their care
  • Practices that only handle Schedule 1 controlled drugs

Licensing Requirements

To obtain a WDA(H), businesses must meet specific requirements regarding personnel, premises, systems, and documentation:

Personnel Requirements

  • Appointment of a Responsible Person (RP) with appropriate qualifications and experience
  • Sufficient staff with appropriate training and skills
  • Documented organizational structure and responsibilities

Premises Requirements

  • Suitable storage facilities appropriate for the types of medicines stored
  • Equipment for temperature monitoring and control where required
  • Adequate security measures
  • Designated areas for receiving, storage, and dispatch of medicines
  • Separate areas for returned or recalled products

System Requirements

  • Quality Management System compliant with GDP
  • Standard Operating Procedures covering all distribution activities
  • Traceability system for all medicinal products
  • Process for handling discrepancies, complaints, and recalls
  • Self-inspection schedule

The Responsible Person (RP)

At least one Responsible Person must be named on the WDA(H). The RP has overarching responsibility for ensuring the licensed operation complies with GDP requirements. Key responsibilities include:

  • Maintaining and improving the quality system
  • Ensuring all staff receive appropriate training
  • Approving suppliers and customers
  • Monitoring environmental conditions in storage areas
  • Conducting or overseeing self-inspections
  • Implementing recall procedures when necessary

The RP must be continuously available during business hours either in person or through their deputies, and must have successfully completed an approved WDA(H) RP examination.

Application Process

The application process for a WDA(H) involves several steps:

1. Preparation

Ensure your business meets all requirements before applying, including appointing a qualified RP, preparing suitable premises, and developing appropriate quality systems and SOPs.

2. Application Submission

Complete the WDA(H) application form from the MHRA website, providing details about your business, premises, RP, and activities to be undertaken.

3. Fee Payment

Pay the required application fee. Fees vary based on the type of licence and number of sites being licensed.

4. MHRA Inspection

Once your application is received, an MHRA inspector will contact you to arrange an inspection of your premises and operations to verify GDP compliance.

5. Licence Issuance

If the inspection is satisfactory, the MHRA will issue your WDA(H). The licence will detail the specific activities and premises covered.

The application process typically takes 8-12 weeks, depending on various factors including MHRA resources and your preparedness for inspection.

Licence Categories and Costs

Licence Category Description Annual Fee
A Standard wholesale distribution of medicinal products 1,450
B Distribution of narcotic and psychotropic substances 2,040
C Distribution of radiopharmaceuticals 1,450
D Distribution of blood or blood-derived products 1,450
E Distribution of gas or gas cylinders 1,450
F Distribution of samples of medicinal products 1,450
Additional charges apply for multiple sites and for inspections required outside normal hours or at short notice.

Maintaining Compliance

Once you have your WDA(H), you must maintain compliance with GDP through:

  • Regular self-inspections (at least annually)
  • Performance of SOP reviews and updates as needed
  • Maintenance of temperature monitoring records
  • Staff training records
  • Receipt and dispatch records for traceability
  • Documentation of any deviations or quality issues

Common Pitfalls

Many WDA(H) holders face compliance challenges with:

  • Inadequate temperature monitoring systems
  • Poor documentation practices
  • Lack of regular self-inspections
  • Failure to maintain appropriate storage conditions
  • Insufficient staff training
  • Non-compliance with Falsified Medicines Directive requirements

Revocation and Enforcement

The MHRA can suspend or revoke a WDA(H) if there is evidence of non-compliance with GDP or risk to the quality of medicines. Enforcement actions may include:

  • Issuing warning letters with requirements for corrective actions
  • Adding special conditions to the licence
  • Temporarily suspending the licence
  • Revoking the licence entirely
  • Criminal prosecution for serious breaches

Looking Forward

The pharmaceutical distribution landscape is evolving, with increasing focus on patient safety, security of the supply chain, and regulatory compliance. The Falsified Medicines Directive introduces additional requirements for wholesale dealers, including:

  • Verification of safety features (anti-tampering devices and unique identifiers)
  • Enhanced systems for reporting suspected falsified medicines
  • Higher standards for documentation and traceability

For anyone looking to enter or remain in the pharmaceutical wholesale distribution sector, understanding and maintaining WDA(H) requirements is essential for both regulatory compliance and business success.

Need assistance with your WDA(H) application or compliance? Professional consultancy services specializing in pharmaceutical wholesale distribution can provide expert guidance tailored to your specific business needs.

Learn More About WDA(H) Compliance
```

Reference Files For Wholesale Dealer S Licence (WDA(H))
Screenshoot
File Name
gn_6_brexit_changes_gdp.pdf

File Size
0.57 MB

File Type
PDF

File Site
Description
This file is just a reference file for Wholesale Dealer S Licence (WDA(H)). Does not guarantee that the specific things you want are included in it.
Direct download (wait 10 seconds)

Wholesale Dealer S Licence (WDA(H)) and Reference File Download Link


admin
Admin
2026-06-08 19:58:15

Dealer Monthly Sales Tax Report and Reference File Download Link


admin
Admin
2026-06-06 07:38:10

Inter Dealer Foreign Exchange Markets and Reference File Download Link


admin
Admin
2026-06-06 19:50:16

Equity Dealer Certification and Reference File Download Link


admin
Admin
2026-06-10 11:56:16

Automotive Repair Dealer Registration Revocation and Reference File Download Link


admin
Admin
2026-06-11 09:38:18